Nanoparticle-mediated drug delivery to treat infections in the female reproductive tract: evaluation of experimental systems and the potential for mathematical modeling

References

• KatzDFYuanAGaoYVaginal drug distribution modelingAdv Drug Deliv Rev20159221325933938
   PubMed Web of Science ®Google Scholar
• LaiSKWangYYWirtzDHanesJMicro- and macrorheology of mucusAdv Drug Deliv Rev20096128610019166889
   PubMed Web of Science ®Google Scholar
• GaoYKatzDFMulticompartmental pharmacokinetic model of tenofovir delivery by a vaginal gelPLoS One201389e7440424040241
   PubMed Web of Science ®Google Scholar
• AcartürkFMucoadhesive vaginal drug delivery systemsRecent Pat Drug Deliv Formul20093319320519925443
   PubMedGoogle Scholar
• CaramellaCMRossiSFerrariFBonferoniMCSandriGMucoadhesive and thermogelling systems for vaginal drug deliveryAdv Drug Deliv Rev201592395225683694
   PubMed Web of Science ®Google Scholar
• EnsignLMConeRHanesJNanoparticle-based drug delivery to the vagina: a reviewJ Control Release201419050051424830303
   PubMed Web of Science ®Google Scholar
• MallipeddiRRohanLCNanoparticle-based vaginal drug delivery systems for HIV preventionExpert Opin Drug Deliv201071374820017659
   PubMed Web of Science ®Google Scholar
• SteinbachJMProtein and oligonucleotide delivery systems for vaginal microbicides against viral STIsCell Mol Life Sci201572346950325323132
   PubMed Web of Science ®Google Scholar
• WhaleyKJHanesJShattockRConeRAFriendDRNovel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccinesAntiviral Res201088Suppl 1S55S6621109069
   PubMed Web of Science ®Google Scholar
• CuYBoothCJSaltzmanWMIn vivo distribution of surface-modified PLGA nanoparticles following intravaginal deliveryJ Control Release2011156225826421763739
   PubMed Web of Science ®Google Scholar
• CuYSaltzmanWMControlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucusMol Pharm20096117318119053536
   PubMed Web of Science ®Google Scholar
• CuYSaltzmanWMDrug delivery: stealth particles give mucus the slipNat Mater2009811113
   PubMed Web of Science ®Google Scholar
• das NevesJAraújoFAndradeFAmijiMBahiaMFSarmentoBBiodistribution and pharmacokinetics of dapivirine-loaded nanoparticles after vaginal delivery in micePharm Res20143171834184524449442
   PubMed Web of Science ®Google Scholar
• das NevesJAraújoFAndradeFIn vitro and ex vivo evaluation of polymeric nanoparticles for vaginal and rectal delivery of the anti-HIV drug dapivirineMol Pharm20131072793280723738946
   PubMed Web of Science ®Google Scholar
• das NevesJNunesRMachadoASarmentoBPolymer-based nanocarriers for vaginal drug deliveryAdv Drug Deliv Rev201592537025550217
   PubMed Web of Science ®Google Scholar
• das NevesJRochaCMGonçalvesMPInteractions of microbicide nanoparticles with a simulated vaginal fluidMol Pharm20129113347335623003680
   PubMed Web of Science ®Google Scholar
• El-HammadiMMAriasJLNano-sized platforms for vaginal drug deliveryCurr Pharm Des201521121633164425354177
   PubMed Web of Science ®Google Scholar
• EnsignLMLaiSKWangYYPretreatment of human cervicovaginal mucus with pluronic F127 enhances nanoparticle penetration without compromising mucus barrier properties to herpes simplex virusBiomacromolecules201415124403440925347518
   PubMed Web of Science ®Google Scholar
• EnsignLMTangBCWangYYMucus-penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virusSci Transl Med20124138138ra79
   PubMed Web of Science ®Google Scholar
• LaiSKO’HanlonDEHarroldSRapid transport of large polymeric nanoparticles in fresh undiluted human mucusProc Natl Acad Sci U S A200710451482148717244708
   PubMed Web of Science ®Google Scholar
• LaiSKWangYYHidaKConeRHanesJNanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than virusesProc Natl Acad Sci U S A2010107259860320018745
   PubMed Web of Science ®Google Scholar
• LemboDSwaminathanSDonalisioMEncapsulation of Acyclovir in new carboxylated cyclodextrin-based nanosponges improves the agent’s antiviral efficacyInt J Pharm20134431–226227223279938
   PubMed Web of Science ®Google Scholar
• LiCHuangZLiuZSulfonate-modified phenylboronic acid-rich nanoparticles as a novel mucoadhesive drug delivery system for vaginal administration of protein therapeutics: improved stability, mucin-dependent release and effective intravaginal placementInt J Nanomedicine20161159175930 eCollection 201627877038
   PubMed Web of Science ®Google Scholar
• MaiselKReddyMXuQNanoparticles coated with high molecular weight PEG penetrate mucus and provide uniform vaginal and colorectal distribution in vivoNanomedicine (Lond)201611111337134327171816
   PubMed Web of Science ®Google Scholar
• FröhlichERobleggEMucus as barrier for drug delivery by nanoparticlesJ Nanosci Nanotechnol201414112613624730255
   PubMed Web of Science ®Google Scholar
• SimsLBCurtisLTFrieboesHBSteinbach-RankinsJMEnhanced uptake and transport of PLGA-modified nanoparticles in cervical cancerJ Nanobiotechnol20161433
   PubMed Web of Science ®Google Scholar
• SimsLBHussMKFrieboesHBSteinbach-RankinsJMDistribution of PLGA-modified nanoparticles in 3D cell culture models of hypo-vascularized tumor tissueJ Nanobiotechnol201715167
   PubMedGoogle Scholar
• SteinbachJMSeoYESaltzmanWMCell penetrating peptide-modified poly(lactic-co-glycolic acid) nanoparticles with enhanced cell internalizationActa Biomater201630496126602822
   PubMed Web of Science ®Google Scholar
• SukJSXuQKimNHanesJEnsignLMPEGylation as a strategy for improving nanoparticle-based drug and gene deliveryAdv Drug Deliv Rev201699Pt A285126456916
   PubMed Web of Science ®Google Scholar
• TangBCDawsonMLaiSKBiodegradable polymer nanoparticles that rapidly penetrate the human mucus barrierProc Natl Acad Sci U S A200910646192681927319901335
   PubMed Web of Science ®Google Scholar
• WangYYLaiSKSoCSchneiderCConeRHanesJMucoadhesive nanoparticles may disrupt the protective human mucus barrier by altering its microstructurePLoS One201166e2154721738703
   PubMed Web of Science ®Google Scholar
• WongTWDhanawatMRathboneMJVaginal drug delivery: strategies and concerns in polymeric nanoparticle developmentExpert Opin Drug Deliv20141191419143424960192
   PubMed Web of Science ®Google Scholar
• WoodrowKACuYBoothCJSaucier-SawyerJKWoodMJSaltzmanWMIntravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNANat Mater20098652653319404239
   PubMed Web of Science ®Google Scholar
• XuQEnsignLMBoylanNJImpact of surface polyethylene glycol (PEG) density on biodegradable nanoparticle transport in mucus ex vivo and distribution in vivoACS Nano2015999217922726301576
   PubMed Web of Science ®Google Scholar
• YangMLaiSKWangYYBiodegradable nanoparticles composed entirely of safe materials that rapidly penetrate human mucusAngew Chem Int Ed Engl201150112597260021370345
   PubMed Web of Science ®Google Scholar
• YangMYuTWangYYVaginal delivery of paclitaxel via nanoparticles with non-mucoadhesive surfaces suppresses cervical tumor growthAdv Healthc Mater2014371044105224339398
   PubMed Web of Science ®Google Scholar
• YuTWangYYYangMBiodegradable mucus-penetrating nanoparticles composed of diblock copolymers of polyethylene glycol and poly(lactic-co-glycolic acid)Drug Deliv Transl Res201222124128
   Web of Science ®Google Scholar
• das NevesJAmijiMSarmentoBMucoadhesive nanosystems for vaginal microbicide development: friend or foe?Wiley Interdiscip Rev Nanomed Nanobiotechnol20113438939921506290
   PubMed Web of Science ®Google Scholar
• MartinDTSteinbachJMLiuJSurface-modified nanoparticles enhance transurothelial penetration and delivery of survivin siRNA in treating bladder cancerMol Cancer Ther2014131718124222663
   PubMed Web of Science ®Google Scholar
• MertOLaiSKEnsignLA poly(ethylene glycol)-based surfactant for formulation of drug-loaded mucus penetrating particlesJ Control Release2012157345546021911015
   PubMed Web of Science ®Google Scholar
• PereiraMNReisTAMatosBNCunha-FilhoMGratieriTGelfusoGMNovel ex vivo protocol using porcine vagina to assess drug permeation from mucoadhesive and colloidal pharmaceutical systemsColloids Surf B Biointerfaces201715822222828697437
   PubMed Web of Science ®Google Scholar
• CuYSaltzmanWMMathematical modeling of molecular diffusion through mucusAdv Drug Deliv Rev200961210111419135488
   PubMed Web of Science ®Google Scholar
• OlmstedSSPadgettJLYudinAIWhaleyKJMoenchTRConeRADiffusion of macromolecules and virus-like particles in human cervical mucusBiophys J20018141930193711566767
   PubMed Web of Science ®Google Scholar
• BoukariHBrichacekBStrattonPMovements of HIV-virions in human cervical mucusBiomacromolecules20091092482248819711976
   PubMed Web of Science ®Google Scholar
• ChenAMcKinleySAShiFModeling of virion collisions in cervicovaginal mucus reveals limits on agglutination as the protective mechanism of secretory immunoglobulin APLoS One2015107e013135126132216
   PubMed Web of Science ®Google Scholar
• FrieboesHBSinekJPNalciogluOFruehaufJPCristiniVNanotechnology in cancer drug therapy: a biocomputational approachFerrariMLeeAPLeeLJBioMEMS and Biomedical NanotechnologyBoston, MASpringer2006
   Google Scholar
• CurtisLTRychahouPBaeYFrieboesHBA computational/experimental assessment of antitumor activity of polymer nanoassemblies for pH-controlled drug delivery to primary and metastatic tumorsPharm Res201633102552256427356524
   PubMed Web of Science ®Google Scholar
• CurtisLTWuMLowengrubJDecuzziPFrieboesHBComputational modeling of tumor response to drug release from vasculature-bound nanoparticlesPLoS One20151012e014488826660469
   PubMed Web of Science ®Google Scholar
• DecuzziPPasqualiniRArapWFerrariMIntravascular delivery of particulate systems: does geometry really matter?Pharm Res200926123524318712584
   PubMed Web of Science ®Google Scholar
• EnglandCGGobinAMFrieboesHBEvaluation of uptake and distribution of gold nanoparticles in solid tumorsEur Phys J Plus201513011 pii: 231
   PubMed Web of Science ®Google Scholar
• FrieboesHBWuMLowengrubJDecuzziPCristiniVA computational model for predicting nanoparticle accumulation in tumor vasculaturePLoS One201382e5687623468887
   PubMed Web of Science ®Google Scholar
• GaoYLiMChenBPredictive models of diffusive nanoparticle transport in 3-dimensional tumor cell spheroidsAAPS J201315381683123605950
   PubMed Web of Science ®Google Scholar
• LeonardFCurtisLTWareMJMacrophage polarization contributes to the anti-tumoral efficacy of mesoporous nanovectors loaded with albumin-bound paclitaxelFront Immunol2017869328670313
   PubMed Web of Science ®Google Scholar
• LeonardFCurtisLTYesantharaoPEnhanced performance of macrophage-encapsulated nanoparticle albumin-bound-paclitaxel in hypo-perfused cancer lesionsNanoscale2016825125441255226818212
   PubMed Web of Science ®Google Scholar
• KorenETorchilinVPCell-penetrating peptides: breaking through to the other sideTrends Mol Med201218738539322682515
   PubMed Web of Science ®Google Scholar
• LiMReinekeJMathematical modelling of nanoparticle biodistribution: extrapolation among intravenous, oral and pulmonary administration routesInt J Nano Biomater201133222238
   Google Scholar
• ReichelDCurtisLTEhlmanEDevelopment of halofluorochromic polymer nanoassemblies for the potential detection of liver metastatic colorectal cancer tumors using experimental and computational approachesPharm Res201734112385240228840432
   PubMed Web of Science ®Google Scholar
• SinekJFrieboesHZhengXCristiniVTwo-dimensional chemotherapy simulations demonstrate fundamental transport and tumor response limitations involving nanoparticlesBiomed Microdevices20046429730915548877
   PubMed Web of Science ®Google Scholar
• van de VenALAbdollahiBMartinezCJModeling of nanotherapeutics delivery based on tumor perfusionNew J Phys20131555004
   PubMed Web of Science ®Google Scholar
• van de VenALWuMLowengrubJIntegrated intravital microscopy and mathematical modeling to optimize nanotherapeutics delivery to tumorsAIP Adv2012211120822489278
   PubMed Web of Science ®Google Scholar
• WuMFrieboesHBChaplainMAMcDougallSRCristiniVLowengrubJSThe effect of interstitial pressure on therapeutic agent transport: coupling with the tumor blood and lymphatic vascular systemsJ Theor Biol201435519420724751927
   PubMed Web of Science ®Google Scholar
• CurtisLTEnglandCGWuMLowengrubJFrieboesHBAn interdisciplinary computational/experimental approach to evaluate drug-loaded gold nanoparticle tumor cytotoxicityNanomedicine (Lond)201611319721626829163
   PubMed Web of Science ®Google Scholar
• CurtisLTFrieboesHBThe tumor microenvironment as a barrier to cancer nanotherapyAdv Exp Med Biol201693616519027739048
   PubMed Web of Science ®Google Scholar
• GodinBDriessenWHPronethBAn integrated approach for the rational design of nanovectors for biomedical imaging and therapyAdv Genet201069316420807601
   PubMed Web of Science ®Google Scholar
• KaddiCDPhanJHWangMDComputational nanomedicine: modeling of nanoparticle-mediated hyperthermal cancer therapyNanomedicine (Lond)2013881323133323914967
   PubMed Web of Science ®Google Scholar
• LiMCzyszczonEAReinekeJJDelineating intracellular pharmacokinetics of paclitaxel delivered by PLGA nanoparticlesDrug Deliv Transl Res20133655156125786375
   PubMed Web of Science ®Google Scholar
• LiMPanagiZAvgoustakisKReinekeJPhysiologically based pharmacokinetic modeling of PLGA nanoparticles with varied mPEG contentInt J Nanomedicine201271345135622419876
   PubMed Web of Science ®Google Scholar
• LuMAl-JamalKTKostarelosKReinekeJPhysiologically based pharmacokinetic modeling of nanoparticlesACS Nano20104116303631720945925
   PubMed Web of Science ®Google Scholar
• LortonSPKummerfeldHLFooteRHPolyacrylamide as a substitute for cervical mucus in sperm migration testsFertil Steril19813522222257202747
   PubMed Web of Science ®Google Scholar
• LaiSKWangYYConeRWirtzDHanesJAltering mucus rheology to “solidify” human mucus at the nanoscalePLoS One200941e429419173002
   PubMed Web of Science ®Google Scholar
• SaltzmanWMRadomskyMLWhaleyKJConeRAAntibody diffusion in human cervical mucusBiophys J1994662 Pt 15085158161703
   PubMed Web of Science ®Google Scholar
• WillitsRKSaltzmanWMSynthetic polymers alter the structure of cervical mucusBiomaterials200122544545211214755
   PubMed Web of Science ®Google Scholar
• GardnerJKHerbst-KralovetzMMThree-dimensional rotating wall vessel-derived cell culture models for studying virus-host interactionsViruses2016811 pii: E304
   Web of Science ®Google Scholar
• HeBChenGZengYThree-dimensional cell culture models for investigating human virusesVirol Sin201631536337927822716
   PubMed Web of Science ®Google Scholar
• LeTTDPhamTHNguyenTNNgoTHGHoangTMNLeQHEvaluation of anti-HER2 scFv-conjugated PLGA-PEG nanoparticles on 3D tumor spheroids of BT474 and HCT116 cancer cellsAdv Nat Sci Nanosci Nanotech201672025004
   Google Scholar
• SobelJDTchaoRBozzolaJLevisonMEKayeDAdherence of bacteria to human vaginal epithelial-cell multilayer tissue-culturesClin Res1979272A481
   Google Scholar
• van EykADvan der BijlPThe culture of human buccal and vaginal epithelial cells for permeability studiesSADJ1998531149750310518919
   PubMedGoogle Scholar
• EnsignLMHenningASchneiderCSEx vivo characterization of particle transport in mucus secretions coating freshly excised mucosal tissuesMol Pharm20131062176218223617606
   PubMed Web of Science ®Google Scholar
• YangMLaiSKYuTNanoparticle penetration of human cervicovaginal mucus: the effect of polyvinyl alcoholJ Control Release201419220220825090196
   PubMed Web of Science ®Google Scholar
• AmsdenBAn obstruction-scaling model for diffusion in homogeneous hydrogelsMacromolecules1999323874879
   Web of Science ®Google Scholar
• WesslerTChenAMcKinleySAConeRForestGLaiSKUsing computational modeling to optimize the design of antibodies that trap viruses in mucusACS Infect Dis201621829226771004
   PubMed Web of Science ®Google Scholar
• KatzDFGaoYJChangSMulti-compartmental transport of anti-HIV molecules into and through mucosaBiophys J20121023594a
   Web of Science ®Google Scholar
• ShenHHuYSaltzmanWMDNA diffusion in mucus: effect of size, topology of DNAs, and transfection reagentsBiophys J200691263964416632500
   PubMed Web of Science ®Google Scholar
• PylesRBVincentKLBaumMMCultivated vaginal microbiomes alter HIV-1 infection and antiretroviral efficacy in colonized epithelial multilayer culturesPLoS One201493e9341924676219
   PubMed Web of Science ®Google Scholar
• SobelJDTchaoRBozzolaJLevisonMEKayeDHuman vaginal epithelial multilayer tissue-cultureIn Vitro197915129931000535911
   PubMedGoogle Scholar
• van EykADvan der BijlPPorcine vaginal mucosa as an in vitro permeability model for human vaginal mucosaInt J Pharm20053051–210511116226413
   PubMedGoogle Scholar
• MengJSturgisTFYouanBBEngineering tenofovir loaded chitosan nanoparticles to maximize microbicide mucoadhesionEur J Pharm Sci2011441–2576721704704
   PubMed Web of Science ®Google Scholar
• EnsignLMHoenTEMaiselKConeRAHanesJSEnhanced vaginal drug delivery through the use of hypotonic formulations that induce fluid uptakeBiomaterials201334286922692923769419
   PubMed Web of Science ®Google Scholar
• GeonnottiARKatzDFCompartmental transport model of microbicide delivery by an intravaginal ringJ Pharm Sci20109983514352120222027
   PubMed Web of Science ®Google Scholar
• JarrettAMGaoYHussainiMYCoganNGKatzDFSensitivity analysis of a pharmacokinetic model of vaginal anti-HIV microbicide drug deliveryJ Pharm Sci201610551772177827012224
   PubMed Web of Science ®Google Scholar
• GaoYYuanAChuchuenOHamAYangKHKatzDFVaginal deployment and tenofovir delivery by microbicide gelsDrug Deliv Transl Res20155327929425874971
   PubMed Web of Science ®Google Scholar
• CasaliniTRossiFLazzariSPeraleGMasiMMathematical modeling of PLGA microparticles: from polymer degradation to drug releaseMol Pharm201411114036404825230105
   PubMedGoogle Scholar
• HalwesMETyoKMSteinbach-RankinsJMFrieboesHBComputational modeling of antiviral drug diffusion from poly(lactic-co-glycolic-acid) fibers and multicompartment pharmacokinetics for application to the female reproductive tractMol Pharm20181541534154729481088
   PubMedGoogle Scholar